Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: A retrospective and observational study
PaperCitations, authors & open-access status
Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: A retrospective and observational study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2023 year and green oa status.
0
Citations
2023
Year
green
OA Status